-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, A8CU1OBwZLFehq+3obTV2APzcw09c6XKwg1xbJqXHQoctVgnAAc6++9vKTeYzbsp Z+EMCq2lG4hMvKrZnQ1KKg== 0001082554-06-000057.txt : 20060605 0001082554-06-000057.hdr.sgml : 20060605 20060605212053 ACCESSION NUMBER: 0001082554-06-000057 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060601 FILED AS OF DATE: 20060605 DATE AS OF CHANGE: 20060605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HADEED FRED T CENTRAL INDEX KEY: 0001231612 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 06887742 BUSINESS ADDRESS: STREET 1: C/O UNITED THERAPEUTICS CORP STREET 2: 1110 SPRING STREET CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS CORP CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1110 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1110 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2006-06-01 0 0001082554 UNITED THERAPEUTICS CORP UTHR 0001231612 HADEED FRED T 0 1 0 0 EVP & CFO Common Stock 2005-06-01 2005-06-01 4 M 0 2561 17.938 A 3561 D Common Stock 2006-06-01 2006-06-01 4 M 0 1258 22.95 A 4819 D Common Stock 2006-06-01 2006-06-01 4 S 0 2561 48.6083 D 2258 D Common Stock 2006-06-01 2006-06-01 4 S 0 1258 48.6065 D 1000 D Employee Stock Options 17.938 2006-06-01 2006-06-01 4 M 0 2561 0 D 2000-12-04 2010-12-04 Common Stock 3819 318793 D Employee Stock Options 22.95 2006-06-01 2006-06-01 4 M 0 1258 0 D 2003-12-31 2013-12-31 Common Stock 1258 317535 D The exercise of stock options and the corresponding sale of 3,819 shares are pursuant to the 10b5-1 Plan adopted by the reporting person on March 12, 2004. /s/ Paul A. Mahon under Power of Attorney 2006-06-05 -----END PRIVACY-ENHANCED MESSAGE-----